Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Triple Negative Breast Neoplasms × Cyclophosphamide × Clear all

Status

Sponsor Class

Study Type

Interventional 72 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Lymphoma 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Microbiota 1 Metabolic Diseases 1 Lymphoma, Follicular 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Immunologic Deficiency Syndromes 1 Immunoglobulin Light-chain Amyloidosis 1 Hormone Refractory Prostate Cancer 1 Fatigue 1 Breast Cancer Organoids 1 Breast Cancer Metastatic 1 Anemia, Aplastic 1

Interventions

Blood Specimen Collection 4 Drug Therapy 3 Specimen Handling 2 Immune Checkpoint Inhibitors 2 Carboplatin 2 Biopsy, Large-Core Needle 2 Biopsy 2 toripalimab 1 tislelizumab 1 taxane 1 sacituzumab govitecan 1 pembrolizumab 1 Zoledronic Acid 1 Prophylactic Mastectomy 1 Paracentesis 1 Neuropsychological Tests 1 Mifepristone 1 Medicine, Chinese Traditional 1 Mastectomy, Segmental 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Immunotherapy 1 Immunohistochemistry 1 Gene Expression Profiling 1 Doxorubicin 1 DNA 1 Cyclophosphamide 1 Combined Modality Therapy 1 Colonoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05916755 2023-06-23

PORTRAIT

Vall d'Hebron Institute of Oncology

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡